These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 19594302

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Strontium ranelate for preventing and treating postmenopausal osteoporosis.
    O'Donnell S, Cranney A, Wells GA, Adachi JD, Reginster JY.
    Cochrane Database Syst Rev; 2006 Oct 18; 2006(4):CD005326. PubMed ID: 17054253
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A review of strontium ranelate and its effect on DXA scans.
    Blake GM, Lewiecki EM, Kendler DL, Fogelman I.
    J Clin Densitom; 2007 Oct 18; 10(2):113-9. PubMed ID: 17485027
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate.
    Bruyere O, Roux C, Detilleux J, Slosman DO, Spector TD, Fardellone P, Brixen K, Devogelaer JP, Diaz-Curiel M, Albanese C, Kaufman JM, Pors-Nielsen S, Reginster JY.
    J Clin Endocrinol Metab; 2007 Aug 18; 92(8):3076-81. PubMed ID: 17566094
    [Abstract] [Full Text] [Related]

  • 29. [The efficacy of strontium ranelate (Osseor) on fractures in osteoporosis].
    Novak S.
    Reumatizam; 2008 Aug 18; 55(2):75-7. PubMed ID: 19024282
    [Abstract] [Full Text] [Related]

  • 30. Strontium ranelate in the prevention of osteoporotic fractures.
    Reginster JY, Malaise O, Neuprez A, Bruyere O.
    Int J Clin Pract; 2007 Feb 18; 61(2):324-8. PubMed ID: 17263720
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Strontium ranelate for the management of osteoporosis.
    Lam S, Zouzias K.
    Consult Pharm; 2008 Jul 18; 23(7):531-7. PubMed ID: 18764671
    [Abstract] [Full Text] [Related]

  • 35. Continuous broad protection against osteoporotic fractures with strontium ranelate.
    Ferrari S.
    Rheumatology (Oxford); 2009 Oct 18; 48 Suppl 4():iv20-4. PubMed ID: 19783590
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Strontium ranelate: an increased bone quality leading to vertebral antifracture efficacy at all stages.
    Ortolani S, Vai S.
    Bone; 2006 Feb 18; 38(2 Suppl 1):19-22. PubMed ID: 16455319
    [Abstract] [Full Text] [Related]

  • 38. Strontium ranelate in osteoporosis.
    Reginster JY.
    Curr Pharm Des; 2002 Feb 18; 8(21):1907-16. PubMed ID: 12171530
    [Abstract] [Full Text] [Related]

  • 39. Prevention of vertebral fractures by strontium ranelate in postmenopausal women with osteoporosis.
    Compston J.
    Osteoporos Int; 2005 Jan 18; 16 Suppl 1():S4-6. PubMed ID: 15480571
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.